Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopaminergic drugs for memory consolidation in older adults, amnestic mild cognitive impairment, and Alzheimer's disease
2015-002027-26Phase 4Unknown
- Sponsor
- University of Bristol
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of ropinirole, levodopa + benserazide, levodopa and benserazide in Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD) (3 arms), sponsored by University of Bristol. Primary endpoints: Number of words retrieved after 12 hours from learning and Number of words retrieved after 7 days from learning. Status: unknown.
02
Drugs
ropinirolelevodopa + benserazidelevodopabenserazide
03
Conditions
Mild Cognitive Impairment (MCI)Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2015-002027-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002027-26.